Amygdala pathology in Parkinson's disease
- PMID: 7879596
- DOI: 10.1007/BF00296485
Amygdala pathology in Parkinson's disease
Abstract
The amygdala undergoes severe pathological changes during the course of Parkinson's disease (PD). Lewy bodies and Lewy neurites are distributed in a specific manner throughout the nuclear complex. The lesional pattern displays only minor interindividual variation. The most prominent changes occur in the accessory cortical and central nuclei. The cortical, accessory basal and granular nuclei show less severe alterations, while the basal and lateral nuclei, as well as the intercalated cell masses, generally remain uninvolved. The amygdala receives a broad range of afferents, allowing integration of exteroceptive information with interoceptive data. It generates major projections to the isocortex (the prefrontal cortex in particular), limbic system (hippocampus and entorhinal region) and centers regulating endocrine and autonomic functions. The specific lesional pattern seen in PD destroys part of the nuclear gray matter and its connections and, thus, may likely contribute to the development of behavioral changes and autonomic dysfunctions.
Similar articles
-
Pattern of brain destruction in Parkinson's and Alzheimer's diseases.J Neural Transm (Vienna). 1996;103(4):455-90. doi: 10.1007/BF01276421. J Neural Transm (Vienna). 1996. PMID: 9617789 Review.
-
Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease.Brain. 2002 Nov;125(Pt 11):2431-45. doi: 10.1093/brain/awf251. Brain. 2002. PMID: 12390970
-
Nigral and extranigral pathology in Parkinson's disease.J Neural Transm Suppl. 1995;46:15-31. J Neural Transm Suppl. 1995. PMID: 8821039 Review.
-
Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology.Acta Neuropathol. 1999 Aug;98(2):157-64. doi: 10.1007/s004010051064. Acta Neuropathol. 1999. PMID: 10442555
-
The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease.Neurology. 1997 Dec;49(6):1570-6. doi: 10.1212/wnl.49.6.1570. Neurology. 1997. PMID: 9409348
Cited by
-
Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.Cold Spring Harb Perspect Biol. 2016 Nov 1;8(11):a023630. doi: 10.1101/cshperspect.a023630. Cold Spring Harb Perspect Biol. 2016. PMID: 27580631 Free PMC article. Review.
-
Hyposmia may predict development of freezing of gait in Parkinson's disease.J Neural Transm (Vienna). 2021 Jun;128(6):763-770. doi: 10.1007/s00702-021-02347-7. Epub 2021 May 20. J Neural Transm (Vienna). 2021. PMID: 34014391
-
Spinal cord involvement in Lewy body-related α-synucleinopathies.J Spinal Cord Med. 2020 Nov;43(6):832-845. doi: 10.1080/10790268.2018.1557863. Epub 2019 Jan 8. J Spinal Cord Med. 2020. PMID: 30620687 Free PMC article.
-
Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons.Am J Hum Genet. 2018 Dec 6;103(6):874-892. doi: 10.1016/j.ajhg.2018.10.018. Epub 2018 Nov 29. Am J Hum Genet. 2018. PMID: 30503521 Free PMC article.
-
Excitatory synaptic structural abnormalities produced by templated aggregation of α-syn in the basolateral amygdala.Neurobiol Dis. 2024 Sep;199:106595. doi: 10.1016/j.nbd.2024.106595. Epub 2024 Jul 6. Neurobiol Dis. 2024. PMID: 38972360 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Medical